Get startedLog in
    Picture of Vicore Pharma Holding AB logo

    VICO — Vicore Pharma Holding AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSucker Stock
    All News

    Brief: Vicore Pharma Gets Grant From LifeArc For VP01 COVID-19 Clinical Study

    Picture of Vicore Pharma Holding AB logoVicore Pharma Holding AB
    29/05/2020 08:05
    May 29 (Reuters) - Vicore Pharma Holding AB  VICOR.ST :
    * LIFEARC AWARDS £ 1.5 MILLION GRANT TO VICORE PHARMA FOR
THE VP01
COVID-19 CLINICAL STUDY
    * STUDY IS A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED
PHASE II
TRIAL IN APPROXIMATELY 100 COVID-19 PATIENTS

Source text for Eikon:  ID:nWkr9YLDVZ 
Further company coverage:  VICOR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Vicore Pharma Holding AB

    See all news